Next Article in Journal
Clinical Evaluation of a New Electronic Periodontal Probe: A Randomized Controlled Clinical Trial
Next Article in Special Issue
Watch the Mime Carefully! A Refractory Interstitial Lung Disease
Previous Article in Journal
Uncovering and Correcting Shortcut Learning in Machine Learning Models for Skin Cancer Diagnosis
Previous Article in Special Issue
A Preliminary Study on the Prognostic Impact of Neutrophil to Lymphocyte Ratio of the Bronchoalveolar Lavage Fluid in Patients with Lung Cancer
 
 
Article
Peer-Review Record

Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Improves the Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Pulmonary Lesions

Diagnostics 2022, 12(1), 41; https://doi.org/10.3390/diagnostics12010041
by Ching-Kai Lin 1,2,3, Hung-Jen Fan 1,4, Zong-Han Yao 1,2, Yen-Ting Lin 1,2, Yueh-Feng Wen 2,3, Shang-Gin Wu 1,2 and Chao-Chi Ho 2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Diagnostics 2022, 12(1), 41; https://doi.org/10.3390/diagnostics12010041
Submission received: 10 November 2021 / Revised: 14 December 2021 / Accepted: 22 December 2021 / Published: 25 December 2021
(This article belongs to the Special Issue Advances in Diagnostic Bronchoscopy)

Round 1

Reviewer 1 Report

1. The manuscript is too difficult to read. The reason is that the method of comparing/explaining the newly developed tool with the existing one is usually very different from usual.

2. Case-control randomization was not done. This would be a limitation of retrospective study, but some of the key factors that can affect the results should be macthed through the well known methods such as Propsensity score matching (PSM). This should minimize postive findings that are actually meaningful but could be missed.

3. In the materials and methods, a diagram showing the overall procedure process is needed. It is necessary to clearly indicate at what point the difference between Case and Control exists.

4. In the materials and methods, 2.3 Diagnostics, explanation on "Gold standard" or "Reference sample" is requiried.

5. The metric of the each test was not appropriate. Tables should be prepared with commonly used metrics such as sensitivity, specificity, and accuracy.

6. When comparining diagnotic yields of 2 methods, use compare AUC methods.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

This article is of interest to readers. However, it needs some modifications in its current state. 

  1. The information on rapid on-site evaluation during the procedure should be detailed (e.g.,Did you use Diff-Quik stain during ROSE?)
  2.  In Table 3, there was no information about the visibility of lesions on chest x-ray between the two groups; CBCT-AF may contribute to improve the diagnostic accuracy of lesions that were not detected on chest x-ray.
  3. There was a significant difference in the rate of guide sheath use between the two groups. Why did such a difference occur? When comparing the diagnostic accuracy between the two groups, the sampling method without the use of guide sheath should be mentioned in the text.
  4. I don't think there was a title for Table 5. An appropriate title should be provided for Table 5.
  5. In the small lesions (<10mm) in Table 5, the diagnostic yield of the CBCT-AF group was significantly higher than that of the Non-AF group. What were the histological findings of these small lesions? In previous reports, it was very difficult to diagnose small lesions (less than 10 mm) via R-EBUS and navigation system. The information on what kind of histological diagnosis was obtained by Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy in this study may be useful for clinicians involved in the diagnosis of PPL.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The revised paper was well written. Therefore, this paper seems to be worth publishing.

Back to TopTop